Skip to content
Screener

Coherus BioSciences CHRS Q2 2026 earnings

Reported August 5, 2026 · After market close

Revenue$14.3MMiss by $98.7K
EPS-$0.19Beat by $0.06
Revenue estimate$14.4M
EPS estimate-$0.25

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$16.0M
EPS estimate-$0.21

FAQ

When did Coherus BioSciences report Q2 2026 earnings?
Coherus BioSciences (CHRS) reported Q2 2026 earnings on August 5, 2026 after market close.
What were Coherus BioSciences's Q2 2026 revenue and EPS?
Coherus BioSciences reported revenue of $14.3M and eps of $-0.19 for Q2 2026.
Did Coherus BioSciences beat estimates in Q2 2026?
Revenue missed the consensus estimate of $14.4M by $98.7K. EPS beat the consensus estimate of $-0.25 by $0.06.
How did Coherus BioSciences's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 39.5% from $10.3M a year earlier and eps grew 44.1% from $-0.34.
Where can I find Coherus BioSciences's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-091188) and the 10-Q periodic report (0001104659-26-091262) directly on SEC EDGAR. The filing index links above go to sec.gov.